SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Human & Experimental Toxicology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Sangster, B.
Right arrow Articles by van Logten, M.J.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Sangster, B.
Right arrow Articles by van Logten, M.J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Study of Sodium Bromide in Human Volunteers, with Special Emphasis on the Endocrine System

B. Sangster

National Poison Control Centre, National Institute of Public Health, P.O. Box 1, Bilthoven, The Netherlands

E.I. Krajnc

Laboratory for General Toxicology, National Institute of Public Health, P.O. Box 1, Bilthoven, The Netherlands

J.G. Loeber

Laboratory for Endocrinology, National Institute of Public Health, P.O. Box 1, Bilthoven, The Netherlands

A.G. Rauws

Unit on Pharmacokinetics, National Institute of Public Health, P.O. Box 1, Bilthoven, The Netherlands

M.J. van Logten

Laboratory for General Toxicology, National Institute of Public Health, P.O. Box 1, Bilthoven, The Netherlands

1 Bromide, 1 mg kg-1 daily, was administered to 21 healthy volunteers (11 females not using oral contraceptives and not pregnant and 10 males, during 8 weeks or 2 full cycles to determine whether ingestion of a dose equal to the acceptable daily intake might induce effects. Special attention was paid to the endocrine system because endocrine changes were predominant in rats receiving sodium bromide (NaBr) in their diets.

2 There was no difference between the results of a full medical history and physical examination at the start and at the end of the experiment.

3 The results from the measured haematological, biochemical and urine analyses did not change during the experiment.

4 In females the plasma bromide concentration rose from 0.08 ± 0.01 mmol 1-1 to 0.97 ± 0.18 mmol 1-1 and in males from 0.08 ± 0.01 mmol 1 -1 to 0.83 ± 0.09 mmol -1 (mean ± s.d.).

5 No changes were observed in the serum concentrations of thyroxine, free thyroxine, thyroxin binding globulin, triiodothyronine, cortisol, testosterone, estradiol and progesterone. Also no changes were observed in the serum concentrations of thyroid stimulating hormone (TSH), prolactin, luteinizing hormone (LH) and follicle stimulating hormone (FSH) before and after the administration of thyroid stimulating hormone releasing hormone (TRH) and luteinizing hormone releasing hormone (LHRH).

Human & Experimental Toxicology, Vol. 1, No. 4, 393-402 (1982)
DOI: 10.1177/096032718200100405


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




Advertisement